As part of its ongoing news coverage of ACC23, the DAIC/dicardiology.com editorial team has condensed significant portions of the 72nd Convocation of the American College of Cardiology Together with the World Congress of Cardiology Scientific Sessions, ACC.23/WCC, which took place on March 6, at the close of the 3-day event held in New Orleans, LA.
Novel Rehab Program Fights Frailty, Boosts Capacity in Advanced HF medscape.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medscape.com Daily Mail and Mail on Sunday newspapers.
May 4, 2021
By Bill Levesque
GAINESVILLE, Fla. (May 4, 2021) University of Florida Health researchers recently became the first to temporarily implant a new device in a patient with congestive heart failure, a procedure that one day could help physicians manage this potentially deadly condition.
Physicians in the UF College of Medicine’s department of urology and division of cardiovascular medicine performed the first-in-human use of the JuxtaFlow® renal negative pressure treatment device in April after enrolling the first patient in a clinical trial to evaluate its safety and effectiveness.
UF Health hopes to enroll up to 10 patients in the trial. Each patient will receive the treatment for 24 hours while they are continually monitored by a member of the research team. After the device is removed, patients will continue to be closely followed for a month.